Effect of stress hyperglycemic ratio on poor in-hospital prognosis in patients with acute myocardial infarction

doi:10.3969/j.issn.1006-7795.2024.03.018

Abstract

Abstract: Objective To explore the predictive value of stress hyperglycemia ratio (SHR) on in-hospital major adverse cardiovascular events (MACEs) in patients with acute myocardial infarction (AMI). Methods A total of 442 AMI patients with complete clinical data from January 2021 to December 2022 in the Department of Cardiology Center, Beijing Tongren Hospital were selected for retrospectively analyzed. SHR was calculated from the first blood glucose within 24 h after admission (ABG)and glycosylated hemoglobin (HbA1c) value. Patients were divided into MACEs group (n=79) and non-MACEs group (n=363) according to in-hospital MACEs. Logistic regression was used to analyze the risk factors for in-hospital MACEs. The receiver operating characteristic (ROC) curve was used to analyze SHR' s predictive value.Results SHR in MACEs group was higher than that in non-MACEs group (1.30±0.44 vs 1.15±0.17, P<0.001). Multiple Logistic regression analysis indicated that elevated SHR level was an independent risk factor for in-hospital MACEs in AMI patients (OR=2.69, 95%CI: 1.26－5.73, P=0.011). ROC curve analysis showed that SHR (AUC=0.63, 95%CI: 0.57－0.70, P<0.001) had a certain predictive value for in-hospital MACEs in AMI patients, with the optimal cut-off value of 1.29, which is better than HbA1c (P=0.011). Conclusion SHR is a risk factor for in-hospital MACEs in AMI patients, and has predictive value for in-hospital MACEs, which is better than HbA1c. The optimal cut-off value is 1.29.

Key words: stress hyperglycemia ratio, hyperglycemia, acute myocardial infarction, major adverse cardiovascular events

CLC Number:

Dong Zheng, Yang Qingmiao, Guo Caixia. Effect of stress hyperglycemic ratio on poor in-hospital prognosis in patients with acute myocardial infarction[J]. Journal of Capital Medical University, 2024, 45(3): 494-500.

0
/ / Recommend

Add to citation manager EndNote|Reference Manager|ProCite|BibTeX|RefWorks

URL: https://journal03.magtech.org.cn/Jweb_sdykdxxb/EN/10.3969/j.issn.1006-7795.2024.03.018

https://journal03.magtech.org.cn/Jweb_sdykdxxb/EN/Y2024/V45/I3/494

References

［1］ Castro-Dominguez Y, Dharmarajan K, McNamara R L. Predicting death after acute myocardial infarction［J］. Trends Cardiovasc Med, 2018, 28(2): 102－109.
［2］ Vogel B, Claessen B E, Arnold S V, et al. ST-segment elevation myocardial infarction［J］. Nat Rev Dis Primers, 2019, 5(1): 39.
［3］ Eddy D, Schlessinger L, Kahn R, et al. Relationship of insulin resistance and related metabolic variables to coronary artery disease: a mathematical analysis［J］. Diabetes Care, 2009, 32(2): 361－366.
［4］中国心血管健康与疾病报告编写组. 中国心血管健康与疾病报告2022概要［J］. 中国循环杂志, 2023, 38(6): 583－612.
［5］ Yancy C W, Jessup M, Bozkurt B, et al. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines［J］. J Am Coll Cardiol, 2013, 62(16): e147-e239.
［6］ Cui C Y, Zhou M G, Cheng, et al. Admission hyperglycemia as an independent predictor of long-term prognosis in acute myocardial infarction patients without diabetes: a retrospective study［J］. J Diabetes Investig, 2020, 12(7): 1244－1251.
［7］ Khalfallah M, Abdelmageed R, Elgendy E, et al. Incidence, predictors and outcomes of stress hyperglycemia in patients with ST elevation myocardial infarction undergoing primary percutaneous coronary intervention［J］. Diab Vasc Dis Res, 2020, 17(1): 1479164119883983.
［8］ Keeley E C, Boura J A, Grines C L. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials［J］. Lancet, 2003, 361(9351): 13－20.
［9］ Khalfallah M, Maria D A, Allaithy A. Impact of stress hyperglycemia on No-Reflow phenomenon in patients with ST elevation myocardial infarction undergoing primary percutaneous coronary intervention［J］. Glob Heart, 2022, 17(1): 23.
［10］ Gao S D, Liu Q B, Ding X S, et al. Predictive value of the acute-to-chronic glycemic ratio for in-hospital outcomes in patients with ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention［J］. Angiology, 2020, 71(1): 38－47.
［11］ Dungan K M, Braithwaite S S, Preiser J C. Stress hyperglycaemia［J］. Lancet, 2009, 373(9677): 1798－1807.
［12］ Roberts G W, Quinn S J, Valentine N, et al. Relative hyperglycemia, a marker of critical illness: introducing the stress hyperglycemia ratio［J］. J Clin Endocrinol Metab, 2015, 100(12): 4490－4497.
［13］ Marenzi G, Cosentino N, Milazzo V, et al. Prognostic value of the acute-to-chronic glycemic ratio at admission in acute myocardial infarction: a prospective study［J］. Diabetes Care, 2018, 41(4): 847－853.
［14］ Sia C H, Chan M H H, Zheng H L, et al. Optimal glucose, HbA1c, glucose-HbA1c ratio and stress-hyperglycaemia ratio cut-off values for predicting 1-year mortality in diabetic and non-diabetic acute myocardial infarction patients［J］. Cardiovasc Diabetol, 2021, 20(1): 211.
［15］ Schmitz T, Freuer D, Harmel E, et al. Prognostic value of stress hyperglycemia ratio on short- and long-term mortality after acute myocardial infarction［J］. Acta Diabetol, 2022, 59(8): 1019－1029.
［16］ Xu W, Yang Y M, Zhu J, et al. Predictive value of the stress hyperglycemia ratio in patients with acute ST-segment elevation myocardial infarction: insights from a multi-center observational study［J］. Cardiovasc Diabetol, 2022, 21(1): 48.
［17］ Thygesen K, Alpert J S, Jaffe A S, et al. Fourth universal definition of myocardial infarction (2018)［J］. J Am Coll Cardiol, 2018, 72(18): 2231－2264.
［18］ Joubert M, Hardouin J, Legallois D, et al. Effects of glycaemic variability on cardiac remodelling after reperfused myocardial infarction: evaluation of streptozotocin-induced diabetic Wistar rats using cardiac magnetic resonance imaging［J］. Diabetes Metab, 2016, 42(5): 342－350.
［19］ Chattopadhyay S, George A, Jonh J, et al. Two-hour post-challenge glucose is a better predictor of adverse outcome after myocardial infarction than fasting or admission glucose in patients without diabetes［J］. Acta Diabetol, 2018, 55(5): 449－458.
［20］ Lee T F, Burt M G, Heilbronn L K, et al. Relative hyperglycemia is associated with complications following an acute myocardial infarction: a post-hoc analysis of HI-5 data［J］. Cardiovasc Diabetol, 2017, 16(1): 157.
［21］ Lv J X, Wang C S, Gao X J, et al. Development and validation of dynamic models to predict postdischarge mortality risk in patients with acute myocardial infarction: results from China Acute Myocardial Infarction Registry［J］. BMJ Open, 2023, 13(3): e069505.
［22］ Tang, EW, Wong, et al. Global registry of acute coronary events (GRACE) hospital discharge risk score accurately predicts long-term mortality post acute coronary syndrome［J］. Am Heart J, 2007, 153(1): 29－35.
［23］ Vicent L, Velásquez-Rodríguez J, Valero M M J, et al. Predictors of high Killip class after ST segment elevation myocardial infarction in the era of primary reperfusion［J］. Int J Cardiol, 2017, 248: 46－50.
［24］ Pan W J, Lu H N, Lian B T, et al. Prognostic value of HbA1c for in-hospital and short-term mortality in patients with acute coronary syndrome: a systematic review and meta-analysis［J］. Cardiovasc Diabetol, 2019, 18(1): 169.